Dr Catherine Strader joins Acorda Therapeutics’ board

Acorda Therapeutics has expanded its board of directors with the addition of Dr Catherine Strader.

Dr Strader is currently a founding partner at Synergy Partners R&D Solutions, and prior to co-founding the drug discovery and development network in 2014 was vice president and discovery site head at Merck & Co's New Jersey hub.

She also brings executive leadership experience from Schering-Plough, where she served as executive vice president of discovery research and chief scientific officer between 2002 and 2007.

Dr Ron Cohen, Acorda's president and chief executive officer, said: “Catherine brings decades of experience as both a drug developer and biopharmaceutical business executive with an outstanding track record of achievement.

“I expect her to add significant value to the board and the company as we continue to develop our pipeline and grow our business.”